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Cholera is a diarrheal disease caused by the bacterium Vibrio cholerae. Iron is important 
for survival for this pathogen, both as a regulatory mechanism and as part of enzymes. Although 
the iron-transport mechanisms of V. cholerae have been studied in great detail, it is still unclear 
when these mechanisms are active during infection. But, there is now a method to test the 
expression of these mechanisms. This method is known as the recombination-based in vivo 
expression technology (RIVET) vector. This is a new technology with which one can look at the 
induction of transcription of different genes during infection of infant mice. I have inserted the 
feo gene promoter, which is a ferrous iron uptake mechanism, into this vector. I have then 
incorporated this vector into two cholera strains, so that we can better understand when this 
particular iron uptake mechanism is expressed in vivo. These strains will be able to successfully 














Basic information about V. cholerae 
Cholera, a severe diarrheal disease caused by the bacterium Vibrio cholerae, is an 
important disease both historically and today, especially in developing countries. It severely 
affects developing countries where clean water is not readily available (Sack et al., 2006). It can 
lead to a debilitating enteric disease, and treating it can be difficult both financially and 
physically. One of the tactics that researchers are using to attempt to better understand and 
perhaps fight this pathogen is to look into the iron binding and transport mechanisms of these 
bacteria. Since iron is important for the survival of V. cholerae, understanding the way that these 
iron uptake mechanisms work could be incredibly beneficial to preventing the spread and 
reducing the pathogenicity of this disease. 
 V. cholerae is an enteric bacterial pathogen within by the Vibrio genus. Vibrio are gram-
negative facultatively anaerobic fermentative rods. The pathogen that we are focusing on out of 
this large group of ten species is one species, V. cholerae. This species is identified by the O 
antigen of its lipopolysaccharide (LPS), and there are over 140 serogroups of V. cholerae that are 
characterized in this way. The only known serotypes that cause disease are the ones that also 
produce the cholera toxin, serotypes O1 and O139 (Murray 2005). The cholera A-B toxin is 
encoded on the bacteriophage CTX Φ. Five B subunits form a ring and bind to ganglioside 
receptors on human enteric epithelial cells. The A subunit then reacts with G proteins controlling 
adenylate cyclase, leading to an increase of cyclic AMP in the epithelial cell. The increased 
cAMP leads to a loss of water and ions from the cells, which is the reason that patients who have 
contracted this disease have very watery diarrhea. V. cholerae uses pili that attach to these 
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epithelial cells, as well as chemotaxis proteins, to prevent being washed out with the enormous 
volume of water that is being passed through the intestine (Faruque et al., 1998).  
Through this infectious mechanism, the patient will have symptoms of watery diarrhea 
and vomiting. Because of the loss of water, the patient can also have dehydration, and can go 
into shock without fluid replacement. One of the symptoms that can help to diagnose cholera 
from other enteric diseases is the passage of odorless stools, since the majority of the stool is 
made up of water being lost from cells. It is quite a common disease in developing countries with 
poor hygiene, as it is passed through fecal-oral transmission. The treatment is fairly simple; 
replacement of fluids and electrolytes and the administration of antibiotics such as tetracylcine, 
and with correct treatment, the death rate goes down from 60% to 1% (Murray 2005). It has been 
shown that V. cholerae O1 strains can bind to chitin, which explains the close association of the 
disease with eating raw shellfish (Reidl and Klose 2002). The infectious dose of bacteria is 10
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organisms, since the normal strains of V. cholerae are not particularly acid-tolerant and therefore 
need a large infectious dose to be able to survive passage through the stomach’s low pH. This is 
why contaminated food and water is usually the vector for passage of the disease, since it would 
be difficult for person-to-person transmission to result in such a large infectious dose. There are 
vaccines being developed against this bacterium, and the current vaccines lose their effectiveness 
over a period of only 3 years (Murray 2005). Therefore, it is important to research into other 
areas of protection from this important disease, such as the possibility of stopping the disease 
through knowledge gained from their iron transport mechanisms. 
Iron transport in Vibrio cholerae 
The bacteria V. cholerae has reduced virulence when the amount of iron available is 
reduced (Payne and Finkelstein 1978). This demonstrates how important iron transport is to this 
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pathogen, and it also shows that being able to understand iron transport mechanisms could give 
incredibly valuable insight into methods of reducing the number of people who have to suffer 
from enteric diseases. Many studies have been done showing that iron is incredibly important to 
the ability of these bacteria to infect cells, such as by increasing the amount of iron in animal 
cells, and showing the virulence is increased (Payne and Finkelstein 1978). Yet, even now, we 
have a fairly limited understanding of all of the iron uptake mechanisms and at what point they 
are used. 
It is not easy for a bacterial pathogen to uptake iron while in the human body. Although 
there are usually around 5 grams of iron in the human body, about 75% of it is stored in cells as 
hemoglobin. The majority of the iron not stored as hemoglobin is stored as ferritin in the liver, 
with a small remainder being complexed to iron-binding proteins such as transferrin or 
lactoferrin (Neilands 1995). Survival within a host can be very difficult for a pathogen which 
needs iron. Because these bacteria do need iron, they have developed a large array of iron 
transport mechanisms. One way that bacteria are able to retrieve iron from the host environment 
is through the use of siderophores. These are iron chelating compounds that are used to bind to 
iron in the ferric (+3) state. Ferric iron is found in water with high levels of oxygen, such as the 
human body, and it is insoluble in water. Siderophores bind to ferric iron to form soluble Fe
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complexes, and the microbe is then able to bind to the siderophore and take the iron into the cell 
(Neilands 1995). V. cholerae is a facultative anaerobe, so while in an aerobic environment it uses 
iron to help with cellular respiration to make ATP. V. cholerae can also survive anaerobically, 
and even in this environment there are many reasons that this microorganism needs iron, such as 
the reduction of ribotide precursors of RNA and the production of haem. Also, bacteria use iron 
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in various enzymes, and it is an important regulatory co-factor for bacterial cells. There are many 
reasons that bacteria need iron that are crucial to successful survival. 
Iron uptake mechanisms 
V. cholerae has a variety of ways that it is able to acquire iron from the external 
environment. It is able to make a catechol vibriobactin, a siderophore, which is made up of a 
norspermidine backbone with three dihydroxybenzoate moities. This is the only siderophore that 
has been described for V. cholerae. Besides making its own siderophore, this bacterium can also 
take up siderophores made by other species, such as enterobactin made by Shigella and E. coli, 
as well as fluvibactin and agrobactin that have structures similar to vibriobactin (Andrus et al., 
1983). 
V. cholerae has a poorly understood ferrous iron transporter called Feo. Although much 
is known about the homologous Feo transporter in E. coli, very little is known about the one in 
V. cholerae. In both E. coli and V. cholerae, the transporter is made up three proteins, FeoA, 
FeoB and FeoC. FeoA and FeoB in V. cholerae have 40% homology with the E. coli proteins of 
the same name, while FeoC is the same length in V. cholerae as in E. coli but only has 11% 
amino acid homology (Wyckoff et al., 2006). FeoB is a pore protein, which has a hydrophobic 
region that passes the membrane 7 times. FeoA is a small hydrophilic protein that is associated 
with FeoB in some unknown way to help FeoB perform its function. FeoC is another small 
hydrophilic protein of unknown function. The feoA and feoB genes are adjacent to one another 
and found within an operon, showing that FeoA function may be associated with FeoB. 
Mutations in feoA do not reduce iron-uptake activity as drastically as do mutations in feoB, 
demonstrating that the FeoB protein is the major part of this transport mechanism (Cartron et al., 
2006). Since feoA shows some homology to the Src homology 3 domain, or the SH3 domain, it 
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may help FeoB perform its function by acting to help the G-protein on FeoB by activating its 
GTPase (Cartron et al., 2006). The SH3 like region on the FeoA protein interacts with a G-
protein on FeoB, which regulates the uptake of iron through the FeoB transmembrane pore 
(Cartron et al., 2006). Through tests done with radioactive iron, it was found that the transport of 
iron by Feo was stimulated by addition of the reducing agent ascorbate, which is consistent with 
the hypothesis that Feo transports ferrous iron (Wyckoff et al., 2006). 
Another iron transporter of V. cholerae is FpbABC, which consists of a periplasmic 
binding protein and a cytoplasmic protein of the ABC transporter family. This transport system, 
made up of three proteins, is closely related to one in M. haemolytica, and is an example of one 
of the basic active transport systems within cells. The transport of iron by this mechanism was 
inhibited by the addition of ascorbate, consistent with the hypothesis that it is a ferric transporter 
(Wyckoff et al., 2006).  
 V. cholerae is also able to uptake and use haem. Researchers have identified the haemin 
utilization, or Hut, proteins. HutA is a 77 kDa outer membrane protein which acts as a receptor 
for haem and HutR is very similar to HutA. When a mutant was formed that had hutA and hutR 
genes that did not function, the bacteria could not use hemoglobin as an iron source and could 
only weakly use haem (Mey and Payne 2001). HutB is a 26 kDa inner membrane protein, which 
is potentially a periplasmic binding protein (Henderson and Payne 1994). HutC and HutD make 
up the ABC transporter that transports the haem across the cytoplasmic membrane (Selinger 
2001). The HutR transport system for haem presumably works in much the same fashion. It was 
found that both single mutants in vibriobactin uptake and mutants in haem uptake had little effect 
on the ability of V. cholerae to colonize the intestines, which shows that there are a diversity of 
iron transport mechanisms used by these bacteria (Henderson and Payne 1994).  
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TonB dependent transport systems are also important in V. cholerae. TonB-ExbBD 
complexes transduce energy to the outer membranes of Gram-negative bacteria (Postle, 1990). 
TonB is anchored in the membrane by a single membrane spanning domain. Mutations of tonB 
lead to Gram-negative bacteria that are unable to transport vitamin B12, iron siderophores, or 
haem. The two TonB systems are associated with vibriobactin, enterobactin, ferrichrome and 
haem transport (Occhino et al., 1998).  
V. cholerae iron transport is also regulated by Fur. When there is a high level of iron in a 
cell, iron bound to Fur will bind to promoters of iron-regulated genes, preventing their 
expression, while without iron, these Fur proteins do not bind to and suppress the expression of 
Fur-regulated genes. Fur mutants, which are unable to correctly control their iron uptake 
mechanisms, demonstrate a variety of phenotypes. It has been found that Fur, in addition to 
controlling iron uptake mechanisms, also controls the expression of rhyB. This inhibition of rhyB 
leads to the expression of genes for motility and chemotaxis. Other proteins that are repressed by 
Fur are IrgA, an enterobactin receptor, and IrgB, which is required for transcription of irgA, 
(Watnick et al., 1998). 
 As can be seen, there are many different mechanisms for iron uptake and transport in V. 
cholerae. It may seem that the rationale for exploring all of these different mechanisms is for a 
purely scientific standpoint and that the knowledge gained could not be used for medical 
purposes. Yet, if you look at all of the virulence factors that are regulated by iron, it is easy to see 
that these proteins would be good targets to produce vaccines, since they are highly expressed 
during infection with the pathogen. Therefore, besides the pure knowledge from studying these 
iron transport mechanisms, there is also a practical medical aspect. There is much more work to 
be done on iron transport systems in this bacterial pathogen. There is a need to find the way that 
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the Feo transporter works, and which iron transport systems actually perform during infection of 
mammalian cells. The project that I will be working on is related to these two issues. 
The RIVET vector 
Figure 1: The RIVET vector 
This is a diagram of the integration of 
pGOA1193 (the integrated pIVET) 
into the genome with the pRES 
resolvase substrate. Genes are shown 
as arrows and labeled ( tnpR: resolvase 
substrate, lacZ: β galactosidase, bla: 
ampicillin resistance, neo: kanamycin 
resistance, sacB: sugar sensitivity). 
The res sequences are the filled in 
rectangles, and the mobilization (mob) 
and origin of replication (oriR6K) are 
the open rectangle and closed circuit. 
The grey filled rectangle is the fragment cloned into the pIVET derivative allowing for homologous recombination. 
(Figure from Osorio et al., 2004) 
 
In 2004, Osorio et al. improved a way to screen V. cholerae’s expression of genes. This 
method is called recombination-based in vivo expression technology, or RIVET. This builds off 
a previous method called IVET, or in vivo expression technology. In this new method, two 
cassettes, pGOA1193 (the integrated pIVET in Figure 1) and pRES (the resolvase substrate) are 
inserted into the bacterial DNA. In this method: first, the resolvase substrate, such as pRES or 
pRES1, is conjugated into the V. cholerae strain of interest through mating with E. coli bacteria 
containing the resolvase plasmid. After this mating has occurred, selection is performed on the 
colonies for bacteria that have successfully incorporated the entire vector into their genome 
through a double crossover. The selection occurs through testing for kanamycin resistance, since 
the gene for this resistance, neo, is only found on the resolvase.  
The DNA of interest, in my case the feo promoter, must also be cloned into the 
pGOA1193 vector. This vector contains the resolvase, tnpR, as well as genes which confer the 
ability to use lactose, lacZ, and a gene conferring resistance to ampicillin, bla (Figure 1). This 
vector containing the gene of interest is then conjugated into the V. cholerae strain containing the 
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resolvase created earlier. Once this strain of V. cholerae with the vector incorporated is formed, 
it can be used to test whether the gene of interest is expressed in vivo (Osorio et al., 2005). The 
neo and sacB genes found in the resolvase substrate mean that we can test whether the gene of 
interest is expressed. As stated earlier, neo leads to kanamycin resistance, and sacB leads to 
sucrose sensitivity. This is because when SacB produces toxic products in the presence of 
sucrose. Therefore, if the bacteria have this cassette incorporated into their genomes, they will be 
resistant to kanamycin and sensitive to 10% sucrose. If the gene of interest is expressed, 
however, a different pattern of resistance will be seen. When the gene of interest is expressed, 
the resolvase TnpR will be produced and will lead to recombination between the res sequences 
which flank the neo and sacB genes. This excises these genes, leading to bacteria that are 
kanamycin sensitive and sucrose resistant. After obtaining a strain that has successfully 
incorporated this cassette, there can be many tests done to ascertain when the gene of interest, 
feo, is expressed. The resolution of the cassette is essentially irreversible, so after the gene of 
interest is transcribed, the bacteria will be permanently kanamycin sensitive and sucrose 
resistant. Therefore, the bacteria can be used to infect mouse models, and the resistance pattern 
of the bacteria will show whether the gene was transcribed during the infection.  
This method has been used for large-scale screening for genes in V. cholerae by Osorio et 
al. They were able to successfully use this technique to find genes that were turned on in V. 
cholerae only after the bacteria infected mice. After they made a library of strains that had the 
RIVET vector inserted into different genes, they screened all of the strains so that they could be 
sure to look at genes that did not resolve during growth in L-broth. They then inoculated their 
strains into mice and after a 24 hour infection plated serial dilutions on sucrose plates. 
Afterwards, they took the sucrose resistant strains and found the genomic insert into the plasmid 
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through plasmid DNA purification and electroporation of the plasmid into E. coli. The V. 
cholerae DNA found in the plasmid was then sequenced. In this way they were able to obtain 
forty fusion strains that expressed particular genes to a greater extent during infection than in 
vitro. These genes include three genes related to chemotaxis, thirteen metabolic genes, and 
twelve genes involved in transport across the envelope (Osorio et al., 2005). 
Having a strain such as this one could be an invaluable tool for obtaining important 
knowledge about the Feo transport system. The strains that contain the Feo promoter can be used 
to discover when this iron-transport mechanism is active, such as when the bacteria is grown in 
vivo or in vitro. Also, the V. cholerae strains containing the resolvase substrates can also be used 
in the analysis of other genes with the RIVET vector, since these strains can easily be conjugated 
with pGOA1193 vectors containing other cloned genomic fragments. These strains will be used 













Materials and Methods:  
Bacterial Strains and plasmids 
 The E. coli SM10 λ-pir and DH5α λ-pir competent cells made by Elizabeth Wyckoff 
carrying the appropriate plasmids were mated with the various V. cholerae strains to result in the 
final strains of interest. The V. cholerae strains used, also obtained from Elizabeth Wyckoff, 
were ALV101 and O395. The plasmid pWKS30 was used to transfer the feo DNA into 
pGOA1193. pRES, pRES1 and pGOA1193 were plasmids received from Andrew Camilli at 
Tufts. These were integral to producing the final RIVET strains. The sequences for pRES and 
pGOA1193 are in appendices 1 and 2. 
Primers  
Feo.908.Bgl 5´ TAAAGATCTCTCTTATTTCAGTCAGCGTTTC 3´ 
Feo.1852.rev.Bgl 5´ GGGAGATCTCCCATCACCATCAGTTTCTTTC 3´ 
Vc.lac.147 5´ CCAGCGGTTATGAGGTGTATGG 3´ 
Vc.lac.4321.rev 5´ GCGGAGCGTGTGTGATTTTAGG 3´ 
RIVET.4018.rev 5´ AGCGAAAGGAAACAATGTCGTG 3´ 
RIVET.6123 5´ GATTGTCGCACCTGATTGCC 3´ 
RIVET.9276.rev 5´ TCAAAAACGCCGAGTCCATAAC 3´ 
Media, reagents and growth conditions 
Bacterial strains were stored at -80° C in tryptic soy broth (TSB) and 20% glycerol. All E. coli 
and V. cholerae strains were grown in Luria broth (L broth) or on Luria agar (L agar) at 37° C. 
Antibiotics were used at the following final concentrations:  100 µg ampicillin per ml, 10 µg 




Plasmid DNA Isolation 
Plasmid DNA was isolated using the Sigma plasmid minipreparation procedure, using buffers 
provided in the kit and TE´ (10 µM Tris Cl and 0.1 µM EDTA). First, 3 ml of culture was 
centrifuged, the supernatant removed, and then 200 µl of resuspension buffer was mixed with the 
pellet by pipetting up and down. Then, 200 µl of lysis buffer and 350 µl of neutralization buffer 
were added to the cells, and both were mixed through inversion of the tube. This mixture was 
centrifuged for ten minutes at 13200 rpm, and the supernatant was added to the Sigma 
minipreparation columns, centrifuged for 1 minute at 13200 rpm, and the flow through was 
discarded. The DNA left on the column was washed with 500 µl of optimal wash buffer, then 
centrifuged one minute at 13200 rpm and the supernatant discarded. Then the column was 
washed with 600 µl of wash buffer, then centrifuged one minute at 13200 rpm and the 
supernatant discarded, and then the column was centrifuged one minute at 13200 to dry. The 
DNA was eluted off the column into a clean Eppendorf tube with 100 µl of TE´, which was left 
on the column for one minute and then centrifuged another minute at 13200 rpm. 
Transformation protocol 
Plasmid DNA was transformed into E. coli strains cells using the heat shock method. First, the 
competent cells frozen at -80° C were put on ice until thawed. Then, 2 µl of the plasmid, 
obtained through the plasmid DNA isolation described earlier, was added to competent cells, 
such as SM10 λ-pir and DH5α λ-pir, and this mixture was left on ice for one hour. After this 
time, the cells were subjected to a one minute heat shock at 42° C so that they would uptake the 
plasmid, and then were put in 1 ml L broth to shake at 37° for one hour. After this step, the cells 
were plated on LB agar plates containing the correct antibiotics for selection. Three plates for 
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each transformation were used that received either 10, 100 or 1000 µl, so that adequate 
separation of colonies could occur. 
Polymerase Chain Reaction (PCR) methods 
Pfx PCR: a PCR using the Pfx enzyme was done to amplify the feo promoter from Lou15 DNA. 
This was done using the Platinum Pfx polymerase from Invitrogen, and the associated buffer. 
The Pfx PCR was done in 50 µl. The protocol is as follows: 2 µl of V. cholerae Lou 15 DNA, 10 
µl of Pfx 5X buffer (total dilution of 1X), 7.5 µl of 2 mM dXTP (0.3 mM final concentration of 
each), 0.75 µl of the 20 µM forward primer (Feo.908.Bgl) and 0.75 µl of the 20 µM reverse 
primer (Feo.1852.rev.Bgl) (0.3 µM final concentration each), 1 µl 50 mM MgSO4 (1 mM final 
concentration), 27 µl sterile water, and 1 µl of Pfx DNA polymerase (2.5 units final 
concentration) were used to run the PCR, for a 50 µl final volume. The PCR was run at 94 
degrees for two minutes as a preheat, and then was run for 30 cycles of 94 degrees for 15 
seconds, 55.8 degrees for 30 seconds, and 68 degrees for 1 minute 15 seconds. After the thirty 
cycles, the reaction was completed by another elongation step of 68° C for five minutes. 
Taq PCR: the PCR using Taq was used to test for the desired products of the mating and 
transformation. Templates were 100 µl of an overnight culture centrifuged and resuspended in 1 
ml water. Taq and the associated buffers were obtained from New England Biolabs. It was run as 
follows: 1 µl of template, 1 µl of the forward and reverse primers both at 20 µM (0.2 µM final 
concentration), 2 µl 2 mM dXTPs (0.2 mM final concentration), 2 µl 10X buffer (1 X final 
concentration), 0.2 µl Taq polymerase and 12.8 µl of water (to bring the total volume up to 20 
µl). The PCR was run at 94 degrees for two minutes as a preheat, and then was run for thirty 
cycles of 94 degrees for 45 seconds, optimum annealing temperature (usually 57.8) degrees for 
16 
 
45 seconds, and 72 degrees for 1 minute per 1000 base pairs. After the thirty cycles, the reaction 
was completed by another elongation step of 72° C for five minutes. 
Gel extraction 
The gel extraction was also done using a Sigma kit. The band containing the DNA cut from the 
gel was solubilized with three gel volumes of the gel solubilization solution, heated at 50° C for 
five minutes, and vortexed. The binding column was prepared with 500 µl of the column 
preparation solution and centrifuged for one minute. Then, one gel volume of isopropanol was 
added to the solubilized gel fragment, and the solution is added to the binding column and 
centrifuged at 13200 rpm for one minute, 700 µl at a time. Finally, the column was washed with 
700 µl of the wash solution, centrifuged for one minute at 13200 rpm, centrifuged for one minute 
at 13200 rpm to dry, and the DNA was eluted off the column with 50 µl of the elute solution. 
Ligation 
Ligation was done using T4 ligase from New England Biolabs. The reaction was carried out in 
10 µl with 1 µl 10X NEB4 ligation buffer (final concentration 1X) and 1 µl T4 DNA ligase. For 
the ligation of the feo promoter into pWKS30, ATP was needed, so the final three components 
were 2 µl of the vector (pWKS30 SmaI fragment), 5 µl of the V. cholerae feo promoter and 1 µl 
of 5 mM ATP. The ligation of the feo promoter into the pGOA1193 vector instead used 1.5 µl of 
vector and 6.5 µl of the feo promoter insert, since ATP was not necessary. Both were incubated 
at 16° C overnight. 
Restriction enzyme digest 
All restriction enzyme digests were done using New England BioLabs enzymes and buffers as 
indicated in Table 1. 
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In a 10 µl reaction: 1 µl 10X specific NEB buffer (1X final concentration) 1 µl enzyme (10-20 
units), 6-8 µl of DNA, water was added to a final volume of 10 µl. 
Table 1. Restriction enzymes and buffers: 
Restriction enzyme Buffer 
BglII NEB3 
BamHI NEB3 + BSA 




All gels were made with 0.7 g of agarose for every 100 ml of Tris-Acetate-EDTA buffer (TAE).  
The samples were loaded into the wells through the addition of loading dye, made with 30% 
glycerol and .25% bromophenol blue, with 1 µl of dye to 5 µl of sample, and the samples were 
electrophoresed at 60V. After electrophoresis, the gels were placed in a solution of ethidium 
bromide for staining, and viewed using UV light with a camera connected to a computer. The markers 
used for all gels are ΦX174 digested with HaeIII and λ DNA digested with HindIII, both obtained from 
Elizabeth Wyckoff. 
Mating 
The mating was used for the transfer of the pRES1 plasmid from SM10 (λ pir) into two V. 
cholerae strains, O395 and ALV101. 
Overnight cultures of the SM10 clones containing pRES1 and the V. cholerae strains O395 and 
ALV101 were grown in 3 ml of L-broth, and kanamycin was used in the overnight cultures of 
the two pRES1 clones, while streptoymycin was used in the overnight cultures of the V. cholerae 
strains. 250 µl of each overnight culture was centrifuged in an Eppendorf tube and the 
supernatant was taken off, then the bacteria were resuspended in 5 µl of L broth. ALV101 and 
the SM10 strains containing pRES1 were placed together on one LB plate without antibiotics, 
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and the combinations of ALV101 and both SM10 strains containing pRES1, and O395 and both 
SM10 strains containing pRES1 were also spotted together on different LB plates. After 6 hours 
at 37°, the growth from these plates was put on plates containing both streptomycin and 
ampicillin (amp/strep) using a three phase streak for isolation. Eight single colonies were picked 
from each of these plates and streaked on another amp/strep plate, and these colonies were then 
grown up overnight in L-broth containing streptomycin, of which 3 ml was centrifuged at 13200 


















Integration of the feo promoter into the PGOA1193 vector 
 Since the goal of this project was to ascertain when the Feo iron transport system is 
expressed, its promoter sequence was first integrated into the pGOA1193 vector, the vector that 
contains the resolvase. The feo 5’ untranslated region containing the promoter sequence was 
amplified by taking Lou 15 DNA, or DNA acquired from the Lou 15 strain of V. cholerae, and 
by a PCR using Pfx on this DNA. The PCR was done using the Pfx PCR protocol outlined in the 
Materials and Methods section. The primers used for this PCR were Feo.908.Bgl and 
Feo.1852.Bgl. The agarose gel of the PCR product is shown below (Figure 2) with the PCR 
product in the first lane and the marker ΦX174 HaeIII in the second lane. 
Figure 2: PCR of the V. cholerae feo untranslated region 
Lane 1: feo PCR product 
Lane 2: ΦX174 HaeIII 
 






← product between 872 and 1,078 bp 
 
            
 
 
Although the PCR product seems to be a large smear, there is a brighter area of the smear 
between 872 and 1,078 bp, which matches with the predicted size of the product from this PCR 
of 960 bp. Because the PCR fragment was not pure, I electrophoresed the entire PCR product 
overnight and did a gel extraction using the procedure outlined above. The gels shown below are 
that of the overnight gel (Figure 3) and the final gel extraction of the PCR product (Figure 4). 
Both are shown using the ΦX174 HaeIII ladder. 
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Figure 3: Overnight electrophoresis of feo PCR product 
Lane 1: ΦX174 HaeIII 














Figure 4: Gel electrophoresis of the purified feo PCR product 
Lane 1: ΦX174 HaeIII 











I then ligated the feo promoter, using the ligation procedure outlined earlier, into the pWKS30 
vector that had been cut with SmaI. I then used this vector ligated with the feo promoter to 
transform competent SM10 cells made by Elizabeth Wyckoff using the heat-shock 
transformation protocol outlined in the Materials and Methods section. After growing colonies 
on LB plates with ampicillin, I grew 3.5 ml cultures of four of my clones in L-broth with 
ampicillin, and did another plasmid preparation with the same protocol as outlined before. When 
I examined the plasmid preparations of my clones against the pWKS30 vector that was cut with 







Figure 5: Gel of the plasmid preparations for pWKS30 vector ligated 
with the feo untranslated region                                                                                                           
Lane 1: pWKS30 vector without ligated promoter 
Lane 2: Plasmid preparation of pWKS30+ feo promoter clone 23 
Lane 3: Plasmid preparation of pWKS30+ feo promoter clone 25 
Lane 4: Plasmid preparation of pWKS30+ feo promoter clone 26 






I then was able to take the feo promoter out of the pWKS30 vector using a BglII restriction 
enzyme digest, and ligate it into the pGOA1193 vector. This vector was obtained by doing a 
plasmid preparation on the strain containing pGOA1193 sent by Andrew Camilli at Tufts 
University. Both pGOA1193 and the pWKS30 vector have BglII sites, so this restriction enzyme 
was used to digest both the pGOA1193 vector so that it would be linearized, and to obtain the feo 
promoter fragment from the pWKS30 vector. The gel below (Figure 6) shows both the linearized 
pGOA1193 vector cut with BglII after it has been gel purified, using the Sigma gel purification 
procedure outline above (orange arrow), and the plasmid preparations of the pWKS30 vector 
ligated with the feo promoter (blue arrow). 
Figure 6: Gel of the plasmid preparations of the pWKS30 vector and the feo 
promoter, and the linearized pGOA1193 vector cut with BglII 
Lane 1: Plasmid preparation of pWKS30+feo promoter clone 23 
Lane 2: Plasmid preparation of pWKS30+feo promoter clone 25 
Lane 3: pGOA1193 vector cut with BglII, gel purified 
Lane 4: λ DNA- HindIII – marker 
 
 




The next gel (Figure 7) shows the plasmid preparations of the two most successful ligations of 
the pWKS30 vector with the feo promoter, clones 23 and 25, after being digested with the BglII 
restriction enzyme. 
Figure 7: Overnight gel electrophoresis of the BglII digests of two vectors 
ligated with the feo promoter 
Lane 1: λ DNA- HindIII – marker 
Lanes 2-5:  Plasmid preparation of pWKS30+feo promoter clone 23 cut with 
BglII 
Lanes 6-9: Plasmid preparation of pWKS30+feo promoter clone 25 cut with 
BglII 
        
 
 
The band shown by the blue arrow, migrating at less than 2,027 bp, was the predicted size for the 
feo promoter of 906 bp. I then used the same Sigma gel extraction kit to purify this band, and 
after purification, I electrophoresed the DNA out on another gel to check the size (Figure 8). 
Figure 8: Gel of the purified feo promoter after having been cut out of the pWKS30 vector 
with BglII 
Lane 1: λ DNA- HindIII – marker 
Lane 2: Gel purification of the third band from the Plasmid preparation of pWKS30+feo 
promoter clone 23 cut with BglII 
Lane 2: Gel purification of the third band from the Plasmid preparation of pWKS30+feo 
promoter clone 25 cut with BglII 
Lane 4: ΦX174 HaeIII 
 
 
I ligated the feo promoter, the correctly sized band cut from the plasmid preparation, into the cut 
pGOA1193 vector using the same ligation protocol as outlined in the Materials and Methods 
section. I then used this vector ligated with the feo promoter to do a heat-shock transformation of 
SM10 E. coli cells as outlined earlier. I then picked colonies that grew on an ampicillin plate and 
transferred them onto another ampicillin plate, and I did a Pfx PCR using the same procedure 
with the Feo.908.Bgl and Feo.1852.rev.Bgl vectors to see whether the clones had the feo 
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promoter ligated into the PGOA1193 vector. The results of this PCR are shown below (Figure 
9). 
Figure 9: PCR results of using the feo BglII primers on the ligation of 
the feo promoter into the pGOA1193 vector                                                                
Lane 1: λ DNA- HindIII - marker 
Lane 2: pWKS30 with feo promoter (positive control) 
Lane 3: Empty pGOA1193 vector (negative control) 
Lane 4: pGOA1193with feo promoter clone 1 
Lane 5: pGOA1193with feo promoter clone 2 
Lane 6: pGOA1193with feo promoter clone 3 
Lane 7: pGOA1193with feo promoter clone 4 
Lane 8: PGOA1193 with feo promoter clone 5 
Lane 9: pGOA1193with feo promoter clone 6 
Lane 10: pGOA1193with feo promoter clone 7 
Lane 11: pGOA1193with feo promoter clone 8 
Lane 12: ΦX174 HaeIII 
 
The most promising clones were those which looked most like the positive control, clones 2 and 
6. I then grew up overnight plates of these clones and stored the bacteria with TSB and 20% 
glycerol at -80° C. These are the clones of pGOA1193 ligated with the feo promoter that I used 
in all subsequent experiments. 
Transformation of DH5α (λ pir) cells with pRES1 
The first step in achieving a successful transformation was to test the pRES and pRES1 vectors, 
to be sure that the vectors showed the correct banding pattern when cut with different restriction enzymes, 
and to be sure that the vectors were the correct size. I performed a plasmid preparation using the Sigma 
minipreparation procedure outlined in the Materials and Methods section, to obtain the plasmid DNA. I 
first digested these vectors with the digestion enzymes BamHI, EcoRI and HindIII to check the banding 
patterns, to see if these patterns matched those which would be expected after analyzing the sequence of 








Figure 10: Gel of the pRES vector digested with different 
restriction enzymes 
Lane 1: ΦX174 HaeIII-marker 
Lane 2: λ DNA- HindIII – marker 
Lane 3: Undigested pRES vector 
Lane 4: Undigested pRES1 vector 
Lane 5: pRES vector digested with BamHI 
Lane 6: pRES1 vector digested with BamHI 
Lane 7: pRES vector digested with EcoRI 
Lane 8: pRES1 vector digested with EcoRI 
Lane 9: pRES vector digested with HindIII 




Since pRES and pRES1 should have identical sequences except for a 1 base change difference at 
the resolution crossover site, they should not have different banding patterns. In the first two 
lanes, those that contain the undigested vector, the pRES vector is running at around 6,500 bp 
and the pRES1 vector has bands at both that length and at around 9, 416 bp. Unlinearized vectors 
usually run faster than linearized vectors, due to supercoiling, but as the vector is supposed to be 
12,627 bp, the band running at 9,416 bp seems more likely to be accurate. From the gel, pRES1 
has both bands that migrated the same distance as the pRES bands, and bands that are different. 
This follows from fact that the undigested pRES1 vector shows two different bands, one the 
same as the pRES vector, and one that is larger. After analyzing these bands, I found that the 
lanes containing pRES1 contained the correct size bands after cutting: 7109, 3684 and 1724 for 
BamHI, 7785, 3261 and 1471 for EcoRI, and 6640, 2854, 2109 and 914 for HindIII. These 
correctly sized fragments are shown by the blue circled banding pattern in Figure 10. The pRES 
lanes contained some of these bands, but not all. This led to a hypothesis that the pRES plasmid 
was somehow missing the sequence flanked by the resolvase that would lead to kanamycin 
resistance and sucrose sensitivity. After seeing this phenomenon, I then made sure of the size of 
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the vectors by digesting with NotI, a digest enzyme which only cuts in one place on the vector 
(Figure 11). 
Figure 11: Gel of pRES and pRES1 digested with NotI 
Lane 1: λ DNA- HindIII – marker 
Lane 2: pRES digested with NotI 
Lane 3: pRES1 digested with NotI 
 




The pRES vector digested with NotI runs at around 9,412 bp, while the pRES1 vector digested 
with NotI runs at both 9,412 bp as well as around 12,500 bp. This is consistent with the 
hypothesis that the neo and sacB genes, leading to resistance to kanamycin and sensitivity to 
sucrose, were missing from the plasmid, since these genes are about 3 kb together. The loss of 
these genes from the plasmid is possible if the plasmid were to spontaneously resolve these 
sequences, which could occur depending on the genetic background of the bacteria in which they 
were maintained. To make sure that this is what happened, I grew the strains containing pRES 
and pRES1 on plates containing ampicillin and plates containing kanamycin, and only pRES1 
grew on both plates, demonstrating that some of the bacteria still hold the complete pRES1 
plasmid. I then transformed DH5α (λ pir) E. coli with my plasmid preps of pRES and pRES1, 
using the heat shock method, and grew the resulting transformed cells on media containing Kan. 
The DH5α (λ pir) strain does not contain kanamycin resistance, so the only way these bacteria 
would be kanamycin resistant is by taking up the plasmid. Only the bacteria transformed with 
pRES1 gained kanamycin resistance, so I picked eight single colonies to grow up on a 
kanamycin plate, and then made overnight cultures of these colonies in 3 ml of L-broth with 
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kanamycin to perform a plasmid preparation. I then performed a Sigma plasmid preparation 
using the same procedure to obtain the plasmid DNA from these bacteria. The gel is shown in 
Figure 12. 
Figure 12: Gel of the plasmid 
preparation of the transformation of 
DH5α (λ pir) with pRES1 
Lane 1: λ DNA- HindIII – marker 
Lane 2: DH5α (λ pir) and pRES1 
vector clone 1 
Lane 3: DH5α (λ pir) and pRES1 
vector clone 2 
Lane 4: DH5α (λ pir) and pRES1 
vector clone 3 
Lane 5: DH5α (λ pir) and pRES1 
vector clone 4 
Lane 6: DH5α (λ pir) and pRES1 
vector clone 6 
Lane 7: DH5α (λ pir) and pRES1 
vector clone 7 
Lane 8: DH5α (λ pir) and pRES1 
vector clone 8 
 
From this gel I determined that clone 3 (blue arrow) and clone 7 (orange arrow) were the best 
candidates for further use, since they were brighter than most of the other bands. All bands 
migrated at around 9,416 bp, which is the distance the uncut pRES1 vector which contained the 
correct neo and sacB sequences migrated. These clones will be used in all subsequent 
experiments. 
Transformation of SM10 cells with the pRES1 plasmids 
 After obtaining the plasmids from my transformations of DH5α (λ pir) with pRES1, I 
used these plasmids to transform SM10 E. coli cells. The strain DH5α (λ pir) does not contain 
the correct genes for conjugation with another bacteria, so I must transfer these plasmids to 
SM10, which can successfully mate with other strains of bacteria. This procedure was done using 
the same transformation procedure as outlined in the Materials and Methods section. The strains 
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were grown on plates using ampicillin, because the pRES1 vector confers this resistance to the 
bacteria, and the SM10 strain is already kanamycin resistant. This research is currently ongoing. 
Mating of SM10 cells with pRES1 into O395 and Alv101 V. cholerae 
 After obtaining the SM10 cells containing the pRES1 plasmid, I will mate these bacteria 
into the V. cholerae strains O395 and Alv101 using the protocol for mating outlined in the 
Materials and Methods section. From the overnight culture of the 8 different clones, 100 µl will 
be centrifuged to form a pellet and resuspended in 1 ml of water, and this will be used in PCR 
reactions using the LacZ and Rivet primers, using the Taq PCR procedure outlined in the 
materials and methods section.. 
The most promising clones, which contain the correct pRES sequence, will be grown up 
overnight in streptomycin, and then 40 µl of this growth will be transferred into L-broth 
containing kanamycin, to grow up the strains that correctly incorporated the plasmid. These 













The creation of a strain that could be used to test for the transcription of the feo gene will be a 
very useful tool in ascertaining when this iron transport system is expressed. There were a few 
problems in making this strain, however. The incorporation of the feo promoter into the 
pGOA1193 vector went very smoothly, but the transformation using the pRES and pRES1 
strains did not happen as easily. I first attempted to transform SM10 λ-pir competent cells with 
these plasmids, but as these cells are kanamycin resistant already, I did not select for kanamycin 
resistance donated from the plasmid. This meant that the SM10 cells were transformed with the 
plasmids lacking the neo and sacB sequences, as shown in the results section. This explains why 
when I attempted to undertake the mating with these competent cells and the V. cholerae strains 
none of the strains became kanamycin resistant, since the plasmid within the SM10 cells did not 
contain the neo gene. This was resolved, however, after undertaking the experiments outlined in 
the results section.  
 There are many experiments that should be completed using the successful strain created 
using the RIVET vector integrated with the feo promoter. First the strain must be tested to see 
how often it resolves when outside a host, by growing up the strain in L broth and then testing 
how well it retains kanamycin resistance and sucrose sensitivity. After these initial tests, the 
strain can be observed in a variety of media containing different amounts of iron and different 
types of iron, such as ferrous and ferric, to further ascertain when this iron transport mechanism 
is active. The strain can then be used to infect infant mice, and the strain can then be tested to 
find whether the feo promoter is active during infection with the V. cholerae bacteria. The use of 
this strain to find when the feo gene is expressed could potentially lead to great advances in the 
understanding of the different iron mechanisms which V. cholerae uses. The pGOA1193 vector 
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can also be integrated with other iron transport gene promoters as well as other promoter 
sequences in the V. cholerae gene library, so that further analysis of when this bacteria expresses 






















C. Andrus, Walter M., Crosa J., Payne S., Synthesis of siderophores by pathogenic Vibrio 
species. Curr Microbiol, 9. pp 209–214. (1983). 
J. Butterton, Boyko S., and Calderwood S., Use of the Vibrio cholerae irgA gene as a locus for 
insertion and expression of heterologous antigens in cholera vaccine strains. Vaccine, 11. 
pp1327-1335. (1993) 
M. Cartron, Maddocks S., Gillingham P., Craven C., and Andrews S., Feo - transport of ferrous 
iron into bacteria. Biometals, 19(2). pp 143-157. (2006). 
S. Faruque, Albert M., and Mekalanos J., Epidemiology, Genetics, and Ecology of Toxigenic 
Vibrio cholerae. Microbiology and Molecular Biology Reviews, 62(4). pp 1301-1314. 
(1998). 
D. Henderson, and Payne S., Vibrio cholerae iron transport systems: roles of heme and 
siderophore iron transport in virulence and identification of a gene associated with 
multiple iron transport systems. Infection and Immunity, 62(11). pp 5120-5125. (1994) 
A. Mey and Payne S., Haem utilization in Vibrio cholerae involves multiple TonB-dependent 
haem receptors. Mol. Microbiol, 42. pp 835-849. (2001) 
P. Murray, Rosenthal S., Pfaller M., Medical Microbiology. Elsevier Inc. (2005) 
J. Neilands., Siderophores: structure and function of microbial iron transport compounds. J. Biol. 
Chem, 270. pp 26723-26726. (1995) 
D. Occhino, Wyckoff E., Henderson D., Wrona T., Payne S., Vibrio cholerae iron transport: 
haem transport genes are linked to one of two sets of tonB, exbB, exbD genes. Mol 
Microbiol, 29. pp 1493–1507. (1998). 
31 
 
C. Osorio, Crawford J., Michalski J., Martinez-Wilson H., Kaper J., and Camilli A. Second-
generation recombination-based in vivo expression technology for large scale screening 
for Vibrio cholerae genes induced during infection of the mouse small intestine. Infection 
and Immunity, 73. pp 972-980. (2005) 
K. Postle. TonB and the Gram-negative dilemma. Mol. Microbiol, 4(12). pp. 2019-2025 (1990) 
S. Payne. Iron and virulence in Shigella. Mol. Microbiol, 3(9). pp 1301–1306. (1989) 
S. Payne, and Finkelstein R., The critical role of iron in host-bacterial interactions. J Clin Invest, 
61(6). pp 1428–1440. (1978) 
S. Payne, Wyckoff, E., Murphy, E., Oglesby, A., Boulette M., and Davies N.  Iron and 
pathogenesis of Shigella:  iron acquisition in the intracellular environment. Biometals. 
 19. pp 173-180. (2006) 
J. Reidl, and Klose K., Vibrio cholerae and cholera: out of the water and into the host. FEMS 
Microbiol. 26. pp 125-139. (2002) 
D. Sack, Sack R., Chaignat C., Getting serious about cholera. N Engl J Med, 355. pp 649–651. 
(2006). 
S. Seliger, Mey A., Valle A., and Payne S. The two TonB systems of Vibrio cholerae: redundant 
and specific functions. Mol. Microbiol, 39(3). pp. 801-812 (2001)  
P. Watnick, Butterton J., Calderwood S., The interaction of the Vibrio cholerae transcription 
factors, Fur and IrgB, with the overlapping promoters of two virulence genes, irgA and 
irgB. Gene, 209. pp 65–70 (1998) 




E. Wyckoff, Mey A., Leimbach A., Fisher C., and Payne S., Characterization of ferric and 
ferrous iron transport systems in Vibrio cholerae. J Bacteriol, 188(18). pp. 6515–6523. 
(2006) 




















Appendix 1: pRES sequence 
pRES (pAC1311):  12,627 bp.  VcvchoR' 105-1, VcchrR 1389-247, VclacZ' 1712-3161, res 
3189-3302, neo 3424-4239, sacB 4748-6169, res 6303-6416, Vc'lacZ 6649-8190, bla 9112-9972, 
traI 10982-10213. Note that the genes beginning with "Vc" are V. cholerae sequences for 

































































































































































































































Appendix 2: pGOA1193 sequence 
pIVET5n (pGOA1193): 6,929 bp.  tnpR 39-590, lacZ 605-3679, traJ 4669-4298, 
traK* (extra amino acids fused) 5037-5528, oriR6K 5434-5917, bla 6032-6892. 
 
CTCGAGATCTCAATTGTTCGAATTTAGGATACATTTTTATGCGACTTTTTGGTTACGCACGGGT
ATCAACCAGCCAGCAATCTCTCGATATTCAGGTTCGGGCACTCAAAGACGCAGGCGTGAAAGCA
AATCGCATCTTTACTGACAAGGCATCGGGCAGTTCATGCGATCGGAAAGGGCTGGACTTGCTGA
GGATGAAGGTGGAGGAAGGTGACGTCATCTTGGTGAAGAAACTTGACCGCCTTGGGCGCGATAC
TGCTGACATGATCCAGTTAATAAAAGAGTTTGACGCCCAAGGTGTATCCATTCGGTTTATTGAT
GACGGAATCAGTACCGATGGGGAGATGGGTAAAATGGTTGTCACTATTCTATCTGCAGTGGCCC
AGGCAGAACGACAGAGAATACTAGAGCGTACCAATGAAGGTCGCCAAGAGGCAATGGCAAAAGG
AGTTGTTTTTGGTAGAAAAAGAAAAATAGATAGAGATGCAGTATTAAATATGTGGCAACAGGGG
TTAGGTGCCTCACATATATCAAAAACAATGAATATTGCTCGTTCAACAGTATATAAAGTAATAA
ATGAAAGCAACTAAGGAGGAAAGTCGACATGACCATGATTACGGATTCACTGGCCGTCGTTTTA
CAACGTCGTGACTGGGAAAACCCTGGCGTTACCCAACTTAATCGCCTTGCAGCACATCCCCCTT
TCGCCAGCTGGCGTAATAGCGAAGAGGCCCGCACCGATCGCCCTTCCCAACAGTTGCGCAGCCT
GAATGGCGAATGGCGCTTTGCCTGGTTTCCGGCACCAGAAGCGGTGCCGGAAAGCTGGCTGGAG
TGCGATCTTCCTGAGGCCGATACTGTCGTCGTCCCCTCAAACTGGCAGATGCACGGTTACGATG
CGCCCATCTACACCAACGTAACCTATCCCATTACGGTCAATCCGCCGTTTGTTCCCACGGAGAA
TCCGACGGGTTGTTACTCGCTCACATTTAATGTTGATGAAAGCTGGCTACAGGAAGGCCAGACG
CGAATTATTTTTGATGGCGTTAACTCGGCGTTTCATCTGTGGTGCAACGGGCGCTGGGTCGGTT
ACGGCCAGGACAGTCGTTTGCCGTCTGAATTTGACCTGAGCGCATTTTTACGCGCCGGAGAAAA
CCGCCTCGCGGTGATGGTGCTGCGTTGGAGTGACGGCAGTTATCTGGAAGATCAGGATATGTGG
CGGATGAGCGGCATTTTCCGTGACGTCTCGTTGCTGCATAAACCGACTACACAAATCAGCGATT
TCCATGTTGCCACTCGCTTTAATGATGATTTCAGCCGCGCTGTACTGGAGGCTGAAGTTCAGAT
GTGCGGCGAGTTGCGTGACTACCTACGGGTAACAGTTTCTTTATGGCAGGGTGAAACGCAGGTC
GCCAGCGGCACCGCGCCTTTCGGCGGTGAAATTATCGATGAGCGTGGTGGTTATGCCGATCGCG
TCACACTACGTCTGAACGTCGAAAACCCGAAACTGTGGAGCGCCGAAATCCCGAATCTCTATCG
TGCGGTGGTTGAACTGCACACCGCCGACGGCACGCTGATTGAAGCAGAAGCCTGCGATGTCGGT
TTCCGCGAGGTGCGGATTGAAAATGGTCTGCTGCTGCTGAACGGCAAGCCGTTGCTGATTCGAG
GCGTTAACCGTCACGAGCATCATCCTCTGCATGGTCAGGTCATGGATGAGCAGACGATGGTGCA
GGATATCCTGCTGATGAAGCAGAACAACTTTAACGCCGTGCGCTGTTCGCATTATCCGAACCAT
CCGCTGTGGTACACGCTGTGCGACCGCTACGGCCTGTATGTGGTGGATGAAGCCAATATTGAAA
CCCACGGCATGGTGCCAATGAATCGTCTGACCGATGATCCGCGCTGGCTACCGGCGATGAGCGA
ACGCGTAACGCGAATGGTGCAGCGCGATCGTAATCACCCGAGTGTGATCATCTGGTCGCTGGGG
AATGAATCAGGCCACGGCGCTAATCACGACGCGCTGTATCGCTGGATCAAATCTGTCGATCCTT
CCCGCCCGGTGCAGTATGAAGGCGGCGGAGCCGACACCACGGCCACCGATATTATTTGCCCGAT
GTACGCGCGCGTGGATGAAGACCAGCCCTTCCCGGCTGTGCCGAAATGGTCCATCAAAAAATGG
CTTTCGCTACCTGGAGAGACGCGCCCGCTGATCCTTTGCGAATACGCCCACGCGATGGGTAACA
GTCTTGGCGGTTTCGCTAAATACTGGCAGGCGTTTCGTCAGTATCCCCGTTTACAGGGCGGCTT
CGTCTGGGACTGGGTGGATCAGTCGCTGATTAAATATGATGAAAACGGCAACCCGTGGTCGGCT
TACGGCGGTGATTTTGGCGATACGCCGAACGATCGCCAGTTCTGTATGAACGGTCTGGTCTTTG
CCGACCGCACGCCGCATCCAGCGCTGACGGAAGCAAAACACCAGCAGCAGTTTTTCCAGTTCCG
TTTATCCGGGCAAACCATCGAAGTGACCAGCGAATACCTGTTCCGTCATAGCGATAACGAGCTC
CTGCACTGGATGGTGGCGCTGGATGGTAAGCCGCTGGCAAGCGGTGAAGTGCCTCTGGATGTCG
CTCCACAAGGTAAACAGTTGATTGAACTGCCTGAACTACCGCAGCCGGAGAGCGCCGGGCAACT
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CTGGCTCACAGTACGCGTAGTGCAACCGAACGCGACCGCATGGTCAGAAGCCGGGCACATCAGC
GCCTGGCAGCAGTGGCGTCTGGCGGAAAACCTCAGTGTGACGCTCCCCGCCGCGTCCCACGCCA
TCCCGCATCTGACCACCAGCGAAATGGATTTTTGCATCGAGCTGGGTAATAAGCGTTGGCAATT
TAACCGCCAGTCAGGCTTTCTTTCACAGATGTGGATTGGCGATAAAAAACAACTGCTGACGCCG
CTGCGCGATCAGTTCACCCGTGCACCGCTGGATAACGACATTGGCGTAAGTGAAGCGACCCGCA
TTGACCCTAACGCCTGGGTCGAACGCTGGAAGGCGGCGGGCCATTACCAGGCCGAAGCAGCGTT
GTTGCAGTGCACGGCAGATACACTTGCTGATGCGGTGCTGATTACGACCGCTCACGCGTGGCAG
CATCAGGGGAAAACCTTATTTATCAGCCGGAAAACCTACCGGATTGATGGTAGTGGTCAAATGG
CGATTACCGTTGATGTTGAAGTGGCGAGCGATACACCGCATCCGGCGCGGATTGGCCTGAACTG
CCAGCTGGCGCAGGTAGCAGAGCGGGTAAACTGGCTCGGATTAGGGCCGCAAGAAAACTATCCC
GACCGCCTTACTGCCGCCTGTTTTGACCGCTGGGATCTGCCATTGTCAGACATGTATACCCCGT
ACGTCTTCCCGAGCGAAAACGGTCTGCGCTGCGGGACGCGCGAATTGAATTATGGCCCACACCA
GTGGCGCGGCGACTTCCAGTTCAACATCAGCCGCTACAGTCAACAGCAACTGATGGAAACCAGC
CATCGCCATCTGCTGCACGCGGAAGAAGGCACATGGCTGAATATCGACGGTTTCCATATGGGGA
TTGGTGGCGACGACTCCTGGAGCCCGTCAGTATCGGCGGAATTCCAGCTGAGCGCCGGTCGCTA
CCATTACCAGTTGGTCTGGTGTCAAAAATAATAAATCCCGCGGTGGCGGCCGCTCTAGCCCCAG
CCGACCAGGCTTTCCACGCCCGCGTGCCGCTCCATGTCGTTCGCGCGGTTCTCGGAAACGCGCT
GCCGCGTTTCGTGATTGTCACGCTCAAGCCCGTAGTCCCGTTCGAGCGTCGCGCAGAGGTCAGC
GAGGGCGCGGTAGGCCCGATACGGCTCATGGATGGTGTTTCGGGTCGGGTGAATCTTGTTGATG
GCGATATGGATGTGCAGGTTGTCGGTGTCGTGATGCACGGCACTGACGCGCTGATGCTCGGCGA
AGCCAAGCCCAGCGCAGATGCGGTCCTCAATCGCGCGCAACGTCTCCGCGTCGGGCTTCTCTCC
CGCGCGGAAGCTAACCAGCAGGTGATAGGTCTTGTCGGCCTCGGAACGGGTGTTGCCGTGCTGG
GTCGCCATCACCTCGGCCATGACAGCGGGCAGGGTGTTTGCCTCGCAGTTCGTGACGCGCACGT
GACCCAGGCGCTCGGTCTTGCCTTGCTCGTCGGTGATGTACTTCACCAGCTCCGCGAAGTCTCT
CTTCTTGATGGAGCGCATGGGGACGTGCTTGGCAATCACGCGCACCCCCCGGCCGTTTTAGCGG
CTAAAAAAGTCATGGCTCTGCCCTCGGGCGGACCACGCCCATCATGACCTTGCCAAGCTCGTCC
TGCTTCTCTTCGATCTTCGCCAGCAGGGCGAGGATCGTGGCATCACCGAACCGCGCCGTGCGCG
GGTCGTCGGTGAGCCAGAGTTTCAGCAGGCCGCCCAGGCGGCCCAGGTCGCCATTGATGCGGGC
CAGCTCGCGGACGTGCTCATAGTCCACGACGCCCGTGATTTTGTAGCCCTGGCCGACGGCCAGC
AGGTAGGCCGACAGGCTCATGCCGGCCGCCGCCGCCTTTTCCTCAATCGCTCTTCGTTCGTCTG
GAAGGCAGTACACCTTGATAGGTGGGCTGCCCTTCCTGGTTGGCTTGGTTTCATCAGCCATCCG
CTTGCCCTCATCTGTTACGCCGGCGGTAGCCGGCCAGCCTCGCAGAGCAGGATTCCCGTTGAGC
ACCGCCAGGTGCGAATAAGGGACAGTGAAGAAGGAACACCCGCTCGCGGGTGGGCCTACTTCAC
CTATCCTGCCCGGCTGACGCCGTTGGATACACCAAGGAAAGTCTACACGAACCCTTTGGCAAAA
TCCTGTATATCGTGCGAAAAAGGATGGATATACCGAAAAAATCGCTATAATGACCCCGAAGCAG
GGTTATGCAGCGGAAAAGCGCTGCTTCCCTGCTGTTTTGTGGAATATCTACCGACTGGAAACAG
GCAAATGCAGGAAATTACTGAACTGAGGGGACAGGCGAGAGACGATGCCAAAGAGCTACACCGA
CGAGCTGGCCGAGTGGGTTGAATCCCGCGCGGCCAAGAAGCGCCGGCGTGATGAGGCTGCGGTT
GCGTTCCTGGCGGTGGGGGCGGATGTCGAGGCGGCGTTAGCGTCCGGCTATGCGCTCGTCACCA
TTTGGGAGCACATGCGGGAAACGGGGAAGGTCAAGTTCTCCTACGAGACGTTCCGCTCGCACGC
CAGGCGGCACATCAAGGCCAAGCCCGCCGATGTGCCCGCACCGCAGGCCAAGGCTGCGGAACCC
GCGCCGGCACCCAAGACGCCGGAGCCACGGCGGCCGAAGCAGGGGGGCAAGGCTGAAAAGCCGG
CCCCCGCTGCGGCCCCGACCGGCTTCACCTTCAACCCAACACCGGACAAAAAGGGGCGGATCCG
GCCACGATGCGTCCGGCGTAGAGGATCTGAAGATCAGCAGTTCAACCTGTTGATAGTACGTACT
AAGCTCTCATGTTTCACGTACTAAGCTCTCATGTTTAACGTACTAAGCTCTCATGGCTAACGTA
CTAAGCTCTCATGTTTCACGTACTAAGCTCTCATGTTTGAACAATAAAATTAATATAAATCAGC
AACTTAAATAGCCTCTAAGGTTTTAAGTTTTATAAGAAAAAAAAGAATATATAAGGCTTTTAAA
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GCTTTTAAGGTTTAACGGTTGTGGACAACAAGCCAGGGATGTAACGCACTGAGAAGCCCTTAGA
GCCTCTCAAAGCAATTTTGAGTGACACAGGAACACTTAACGGCTGACATGGGAATTCCACATGT
GGAATTCCACATGTGGAATTGTGAGCGGATAACAATTTGTGGAATTCCCGGGAGAGCTCGATAT
CGCATGCGGTACCTCTAGAAGAAGCTTGGGATCCGCCCCGCGGAACCCCTATTTGTTTATTTTT
CTAAATACATTCAAATATGTATCCGCTCATGAGACAATAACCCTGATAAATGCTTCAATAATAT
TGAAAAAGGAAGAGTATGAGTATTCAACATTTCCGTGTCGCCCTTATTCCCTTTTTTGCGGCAT
TTTGCCTTCCTGTTTTTGCTCACCCAGAAACGCTGGTGAAAGTAAAAGATGCTGAAGATCAGTT
GGGTGCACGAGTGGGTTACATCGAACTGGATCTCAACAGCGGTAAGATCCTTGAGAGTTTTCGC
CCCGAAGAACGTTTTCCAATGATGAGCACTTTTAAAGTTCTGCTATGTGGCGCGGTATTATCCC
GTGTTGACGCCGGGCAAGAGCAACTCGGTCGCCGCATACACTATTCTCAGAATGACTTGGTTGA
GTACTCACCAGTCACAGAAAAGCATCTTACGGATGGCATGACAGTAAGAGAATTATGCAGTGCT
GCCATAACCATGAGTGATAACACTGCGGCCAACTTACTTCTGACAACGATCGGAGGACCGAAGG
AGCTAACCGCTTTTTTGCACAACATGGGGGATCATGTAACTCGCCTTGATCGTTGGGAACCGGA
GCTGAATGAAGCCATACCAAACGACGAGCGTGACACCACGATGCCTGCAGCAATGGCAACAACG
TTGCGCAAACTATTAACTGGCGAACTACTTACTCTAGCTTCCCGGCAACAATTAATAGACTGGA
TGGAGGCGGATAAAGTTGCAGGACCACTTCTGCGCTCGGCCCTTCCGGCTGGCTGGTTTATTGC
TGATAAATCTGGAGCCGGTGAGCGTGGGTCTCGCGGTATCATTGCAGCACTGGGGCCAGATGGT
AAGCCCTCCCGTATCGTAGTTATCTACACGACGGGGAGTCAGGCAACTATGGATGAACGAAATA
GACAGATCGCTGAGATAGGTGCCTCACTGATTAAGCATTGGTAAATCGTACGAGCCGGTGCTAT
CAAAGCACCGGCTTTTT 
 
